TARGETING PIM KINASE/LNCH19 AXIS IN ENZALUTAMIDE-RESISTANT PROSTATE CANCER

$307,000FY2018Department of the ArmyDOD

University Of Arizona, Tucson AZ

Investigators

View source on USAspending →